- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT03821103
Incentivizing Buprenorphine-Naloxone Initiation in Emergency Departments
연구 개요
상세 설명
Philadelphia is experiencing a significant opioid crisis. Through this novel pilot study, critical training about opioid use disorder and medication-assisted treatment with buprenorphine-naloxone will be provided to emergency providers and changes in clinical practice will be incentivized in order to optimize treatment engagement for patients with opioid use disorder in the Emergency Department.
Participants will be invited to participate in a brief in-person training session, will receive a pre- and post-session knowledge and attitude assessment, and will be invited to self-report first-time buprenorphine-naloxone Emergency Department administration within the 3 month study period.
Participants will be randomized to one of two arms: standard training arm and behavioral economic enhanced arm. The standard training arm will receive the aforementioned intervention. The behavioral economic enhanced arm will additionally receive an opt-out invitation, loss-framed incentivization, and weekly tailored text message-based reminders.
Endpoints of interest include retained knowledge and change in provider attitudes regarding Emergency department buprenorphine-naloxone administration and treatment following training and again at 3 months, and first-time Emergency department administration of buprenorphine-naloxone.
연구 유형
등록 (실제)
단계
- 해당 없음
연락처 및 위치
연구 장소
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, 미국, 19104
- University of Pennsylvania Health System
-
-
참여기준
자격 기준
공부할 수 있는 나이
- 어린이
- 성인
- 고령자
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Residents and Advanced Practice Providers and attending clinicians working in emergency departments in Pennsylvania.
Exclusion Criteria:
-
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 건강 서비스 연구
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 더블
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
---|---|
실험적: Standard training arm
The standard training arm will consist of (1) in-person training with pre- and post-session knowledge and attitude assessment, (2) three month post-session knowledge and attitude assessment and (3) self-report of first-time buprenorphine-naloxone Emergency Department administration within 3 month study period.
|
The training includes of (1) in-person training with pre- and post-session knowledge and attitude assessment, (2) three month post-session knowledge and attitude assessment and (3) self-report of first-time buprenorphine-naloxone Emergency Department (ED) administration within 3 month study period
|
실험적: Behavioral economic enhanced arm
The behavioral economic enhanced training arm will consist of (1) in-person training with pre- and post-session knowledge and attitude assessment, (2) three month post-session knowledge and attitude assessment and (3) self-report of first-time buprenorphine-naloxone Emergency Department administration within 3 month study period in addition to an opt-out invitation, loss-framed incentivization, and weekly tailored text message-based reminders
|
The training includes of (1) in-person training with pre- and post-session knowledge and attitude assessment, (2) three month post-session knowledge and attitude assessment and (3) self-report of first-time buprenorphine-naloxone Emergency Department (ED) administration within 3 month study period
Behavioral economic enhancement includes an opt-out invitation, loss-framed incentivization, weekly tailored text based reminders
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Change in Emergency Department initiated buprenorphine-naloxone treatment
기간: One year
|
Measuring number of providers who have initiated at least one first dose of buprenorphine-naloxone
|
One year
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Training Attendance
기간: First week
|
Measure the number of clinicians who attend the training with the incentive.
|
First week
|
Change in attitude about buprenorphine-naloxone Questionaire
기간: Three months
|
The scale is not a validated tool. It is a construct to measure attitudes about buprenorphine-naloxone. It is a Likert scale 1-5, 1 being strongly disagree and 5 being strongly agree. Higher values signify more favorable outcomes. |
Three months
|
기타 결과 측정
결과 측정 |
측정값 설명 |
기간 |
---|---|---|
Retained knowledge of buprenorphine-naloxone treatment Questionaire
기간: Three months
|
Compare retention of knowledge and assessment from before and after the training in the two arms.The scale is not a validated tool. It is a construct of questions to measure retained knowledge about buprenorphine-naloxone initiation. The scale is a percentage of questions answered correctly. Minimum score is 0% and maximum score is 100%. Higher values signify more favorable outcomes. |
Three months
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Jeanmarie Perrone, MD, University of Pennsylvania
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (실제)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .
Training에 대한 임상 시험
-
Seattle Children's HospitalLouisiana State University Health Sciences Center in New Orleans완전한
-
Queens College, The City University of New York완전한
-
Johns Hopkins Bloomberg School of Public HealthWorld Bank; Fundacion Plan International Espana; Global Alliance for Clean Cookstoves완전한
-
Dartmouth-Hitchcock Medical CenterCenters for Disease Control and Prevention완전한
-
Dartmouth-Hitchcock Medical CenterCenters for Disease Control and Prevention모병
-
Training and Implementation Associates모병전통적인 대면 교육 | FTTIP(가족 치료 교육 및 구현 플랫폼)미국
-
Chang Gung Memorial Hospital모병